Lv11
48 积分 2021-12-07 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
2小时前
已关闭
CDK4/6抑制剂在激素受体阳性晚期乳腺癌一线治疗中的挑战及进展后策略
24天前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
4个月前
已完结
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
4个月前
已关闭
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
6个月前
已完结
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
6个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
6个月前
已完结
皖公网安备34019202002308
